Eli Lilly's Orforglipron, an anti-obesity pill,...
Vous n'êtes pas connecté
Eli Lilly's Orforglipron, an anti-obesity pill,...
Eli Lilly's Orforglipron, an anti-obesity pill,...
Eli Lilly & Co.’s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the...
Eli Lilly & Co.’s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the...
Eli Lilly bets on next-generation obesity candidates like orforglipron and retatrutide to sustain growth amid rising competition.
Eli Lilly bets on next-generation obesity candidates like orforglipron and retatrutide to sustain growth amid rising competition.
INDIANAPOLIS, June 21, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from ACHIEVE-1, a Phase 3 trial...
By Madison Muller, Bloomberg News Eli Lilly & Co.’s experimental weight loss pill helped patients shed pounds without serious side effects in a...
By Madison Muller, Bloomberg News Eli Lilly & Co.’s experimental weight loss pill helped patients shed pounds without serious side effects in a...
Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy is a once-weekly...
Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy is a once-weekly...